MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers

Published:2013-05-11 Issue:6 Volume:27 Page:772-778
ISSN:0268-8697
Container-title:British Journal of Neurosurgery
language:en
Short-container-title:British Journal of Neurosurgery

Author:

Gutenberg A.,Bock H. C.,Brück W.,Doerner L.,Mehdorn H. M.,Roggendorf W.,Westphal M.,Felsberg J.,Reifenberger G.,Giese A.

Publisher

Informa UK Limited

Subject

Neurology (clinical),General Medicine,Surgery

Link

http://www.tandfonline.com/doi/pdf/10.3109/02688697.2013.791664

Reference29 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and Its Interaction with DNA

3. Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy

4. Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

5. Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent Glioma

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GammaTile® (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials;Journal of Neuro-Oncology;2024-01-28

2. Brain Cancer Treatment; A Systematic Review;International Journal of Cancer Management;2022-07-30

3. Bisulfite profiling of the MGMT promoter and comparison with routine testing in glioblastoma diagnostics;Clinical Epigenetics;2022-02-18

4. The influence of the blood–brain barrier in the treatment of brain tumours;Journal of Internal Medicine;2022-01-17

5. GammaTile® brachytherapy in the treatment of recurrent glioblastomas;Neuro-Oncology Advances;2021-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3